December 2020 Archives by thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Tue Dec 1 06:49:26 PST 2020
Ending: Thu Dec 31 03:12:06 PST 2020
Messages: 49

• [Ip-health] New ViiV license with the Medicines Patent Pool expands access but eviscerates transparency   Baker, Brook
  • [Ip-health] New ViiV license with the Medicines Patent Pool expands access but eviscerates transparency   Ed Silverman
  • [Ip-health] New ViiV license with the Medicines Patent Pool expands access but eviscerates transparency   Baker, Brook
    • [Ip-health] New ViiV license with the Medicines Patent Pool expands access but eviscerates transparency   Mohga Kamal-Yanni
• [Ip-health] NEW South Centre Research Paper: Designing Pro-Health Competition Policies in Developing Countries   Anna Bernardo
• [Ip-health] Covid Pfizer vaccine approved for use next week in UK   Susan Isiko Strba
• [Ip-health] NEW South Centre Research Paper: Guía para la concesión de licencias obligatorias y uso gubernamental de patentes farmacéuticas   Anna Bernardo
• [Ip-health] $1.8 Billion Sanofi Vaccine Contract Contains International Reference Pricing Clause, Preserves Standard IP and Data Rights   kathryn ardizzone
• [Ip-health] Health Policy Watch: Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week   Luis Gil Abinader
• [Ip-health] New York Time: U.K. Approves Pfizer Coronavirus Vaccine, a First in the West   Thiru Balasubramaniam
• [Ip-health] The Lancet on the TRIPS waiver proposal   Thiru Balasubramaniam
• [Ip-health] Washington Post: A gamble pays off in ‘spectacular success’: How the leading coronavirus vaccines made it to the finish line   Thiru Balasubramaniam
• [Ip-health] Want Vaccines Fast? Suspend Intellectual Property Rights   K.M. Gopakumar
  • [Ip-health] Want Vaccines Fast? Suspend Intellectual Property Rights   Paul Fehlner
    • [Ip-health] Want Vaccines Fast? Suspend Intellectual Property Rights   George Carter
    • [Ip-health] Want Vaccines Fast? Suspend Intellectual Property Rights   Dean Baker
• [Ip-health] Statement: Trump’s vaccine order is a false choice   Peter Maybarduk
• [Ip-health] TWN Info: US & allies adopt "diversionary" tactics to block TRIPS waiver   Chee Yoke Ling
• [Ip-health] A payoff for U.S. taxpayers? CDC may have claims on remdesivir patents held by Gilead   Ed Silverman
• [Ip-health] Call for applications: MPP looking for two new Board Members   Sophie Thievenaz
• [Ip-health] Report: How Biden can accelerate global vaccine access   Peter Maybarduk
• [Ip-health] The Medicines Patent Pool sublicenses sutezolid, an investigational drug for TB treatment, paving the way for clinical development   Sophie Thievenaz
• [Ip-health] South Africa on fire: closing innings at the WTO TRIPS Council (10 December 2020)   Thiru Balasubramaniam
• [Ip-health] No consensus on TRIPS talks - Geneva Health Files   Priti Patnaik
• [Ip-health] Natco Pharma: Hyderabad-based Natco Pharma wants to make Eli Lilly’s Covid drug - The Economic Times   James Love
• [Ip-health] WTO: Members to continue discussion on proposal for temporary IP waiver in response to COVID-19   Thiru Balasubramaniam
• [Ip-health] Fwd: TWN Info: COVID-19 - TRIPS waiver gains more support despite efforts to stall its passage   Chee Yoke Ling
• [Ip-health] New research synthesis - Biosecurity Research and Development (R&D)   Marcela Vieira
• [Ip-health] Scaling production of vaccines and therapeutics. What can be done, what went wrong.   James Love
• [Ip-health] Deadline extended: Call for new members Communities Delegation to Unitaid Board   Wim Vandevelde
• [Ip-health] Panel discussion on “TRIPS Waiver Proposal – State of play and Way forward”   K.M. Gopakumar
• [Ip-health] How The ‘Know-How Gap’ Might Impact Scale-Up Of Covid-19 Vaccines And Treatments   Kaitlin Mara
• [Ip-health] At WTO, a battle for access to COVID-19 vaccines   Baker, Brook
• [Ip-health] Supreme Court ruled in supportive of drug price regulations in olanzapine patent case   Heesob Nam
• [Ip-health] KEI Files Amicus Brief in GlaxoSmithKline vs Teva Induced Infringement Case   Claire Cassedy
• [Ip-health] NEW South Centre Research Paper: Revisiting the Question of Extending the Limits of Protection of Pharmaceutical Patents and Data Outside the EU   Anna Bernardo
• [Ip-health] Rep. Lloyd Doggett and Charles Duan: Why patents on COVID-19 treatments, vaccines should be suspended   Luis Gil Abinader
• [Ip-health] Politico: Belgian secretary of state accidentally reveals EU vaccine prices   Thiru Balasubramaniam
• [Ip-health] Stephen Buranyi opinion piece in The New York Times: Big Pharma Is Fooling Us   Thiru Balasubramaniam
• [Ip-health] Reuters: Pfizer irked after Belgian politician publishes COVID-19 vaccine prices   Thiru Balasubramaniam
• [Ip-health] 18 December 2020 - EU Statement at the WTO General Council - ITEM 13 TRIP COUNCIL MATTERS   Thiru Balasubramaniam
• [Ip-health] 18 December 2020 - India's General Council statement on the Status Report on the Consideration by the TRIPS Council of the ‘Proposal for Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19’   Thiru Balasubramaniam
• [Ip-health] Guardian: Belgian minister tweets EU's Covid vaccine price list to anger of manufacturers   Thiru Balasubramaniam
• [Ip-health] TRIPS Waiver Update from WTO GC meeting   Priti Patnaik
• [Ip-health] Mutating SARS-CoV-2   George Carter
• [Ip-health] New York Times: For Covid-19 Vaccines, Some Are Too Rich — and Too Poor   Thiru Balasubramaniam
• [Ip-health] Al Engleberg on the legacy of Hatch-Waxman, in Stat   James Love
• [Ip-health] WSJ: AstraZeneca and Oxford’s Bumpy Partnership Hangs Over Covid Vaccine’s Future   Thiru Balasubramaniam
• [Ip-health] EB 148: WHO board paper on expanding access to effective treatments of cancer and rare and orphan diseases including cell and gene-based therapies   Thiru Balasubramaniam

Last message date: Thu Dec 31 03:12:06 PST 2020
Archived on: Thu Dec 31 03:25:05 PST 2020

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...